A look at Exact Sciences Corporation’s acquisition by Abbott: review EXAS revenue growth, margins, and CRC/MRD screening ...

A blood-based colorectal cancer (CRC) screening test, SimpleScreen™, has shown a significant leap in performance, ...

SAGA Diagnostics launches its ultrasensitive Pathlight MRD test for colorectal cancer, building on its success in early-stage ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield blood test for ...

New global initiative urges patients and clinicians to wait for biomarker testing results before starting treatment.

Execute a pivotal program for potential best-in-class BTK degrader, bexobrutideg, including Phase 2 and confirmatory Phase 3 studies to support ...

China has broken a record by installing a massive hypergravity machine that can "compress" time and space for the benefit of ...

Guardant co-CEO Helmy Eltoukhy says the shift to personalized treatment and earlier diagnosis is here at the WIRED Health ...

Pfizer Inc. (NYSE: PFE) today announced positive results from Cohort 3, a separate randomized cohort of the pivotal BREAKWATER trial, evaluating ...

The Independent Examinations Board (IEB) has achieved an overall pass rate of 98.31% for the 2025 matric exams.

Investing.com -- Exelixis Inc (NASDAQ:EXEL) stock rose 3.8% and Natera Inc (NASDAQ:NTRA) shares gained 1.6% Wednesday after ...